Compounds > fludarabine

fludarabine and zidovudine

fludarabine has been researched along with zidovudine in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (12.50)	18.2507
2000's	7 (87.50)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Björck, L; Clausen, AR; Piskur, J; Sandrini, MP; Shannon, O	1
Lombardo, F; Obach, RS; Waters, NJ	1
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M	1
Lundberg, JH; Tefferi, A; Weitz, JJ; Witzig, TE	1
Casabianca, A; Celeste, AG; Chiarantini, L; Fraternale, A; Magnani, M; Schiavano, GF; Tonelli, A	1
Brandi, G; Casabianca, A; Chiarantini, L; Fraternale, A; Magnani, M; Tonelli, A	1
Brandi, G; Casabianca, A; Chiarantini, L; Fraternale, A; Magnani, M; Orlandi, C; Silvestri, G	1

Other Studies

8 other study(ies) available for fludarabine and zidovudine

Article	Year
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Deoxyribonucleoside kinases activate nucleoside antibiotics in severely pathogenic bacteria. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:8 Topics: Animals; Anti-Bacterial Agents; Deoxycytidine; Female; Gemcitabine; Humans; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Molecular Sequence Data; Nucleosides; Phosphotransferases (Alcohol Group Acceptor); Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus pyogenes	2007
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors. Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21 Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship	2008
Treatment of refractory T-cell chronic lymphocytic leukemia with purine nucleoside analogues. Leukemia & lymphoma, 1994, Volume: 14, Issue:1-2 Topics: 2-Chloroadenosine; Anemia; Antineoplastic Combined Chemotherapy Protocols; CD3 Complex; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cyclophosphamide; Deoxyadenosines; Fatal Outcome; Female; Humans; Immunophenotyping; Leukemia, Prolymphocytic; Leukemia, Prolymphocytic, T-Cell; Male; Methotrexate; Middle Aged; Neoplastic Stem Cells; Prednisone; Salvage Therapy; Vidarabine; Vincristine; Zidovudine	1994
New treatment protocol including lympholytic and antiretroviral drugs to inhibit murine AIDS. Journal of acquired immune deficiency syndromes (1999), 2000, Feb-01, Volume: 23, Issue:2 Topics: Animals; Anti-HIV Agents; Antineoplastic Agents; DNA, Viral; Drug Administration Schedule; Drug Therapy, Combination; Flow Cytometry; Mice; Murine Acquired Immunodeficiency Syndrome; Vidarabine; Viral Load; Zidovudine	2000
New drug combinations for the treatment of murine AIDS and macrophage protection. European journal of clinical investigation, 2001, Volume: 31, Issue:3 Topics: Animals; Anti-HIV Agents; Antiviral Agents; Drug Combinations; Female; Macrophages; Mice; Mice, Inbred C57BL; Murine Acquired Immunodeficiency Syndrome; Vidarabine; Zidovudine	2001
Repeated cycles of alternate administration of fludarabine and Zidovudine plus Didanosine inhibits murine AIDS and reduces proviral DNA content in lymph nodes to undetectable levels. Virology, 2002, Oct-25, Volume: 302, Issue:2 Topics: Animals; Anti-HIV Agents; Antineoplastic Agents; Didanosine; DNA, Viral; Drug Administration Schedule; Drug Therapy, Combination; Female; Leukemia Virus, Murine; Lymph Nodes; Mice; Mice, Inbred C57BL; Murine Acquired Immunodeficiency Syndrome; Proviruses; Reverse Transcriptase Inhibitors; Treatment Outcome; Vidarabine; Zidovudine	2002